Georgia Capital (CGEO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
27 Oct, 2025Executive summary
NAV per share (GEL) rose 7.9% quarter-on-quarter in 3Q25, driven by strong operating performance in large private portfolio companies and Lion Finance Group's 8.1% share price increase.
Net income reached GEL 282.8 million in 3Q25 and GEL 1,271.6 million in 9M25, marking a significant turnaround from prior year losses.
GEL 700 million capital return programme is underway, with over GEL 400 million deployed, including a new US$50 million share buyback and early redemption of US$100 million in bonds.
S&P upgraded the corporate credit outlook to positive, reflecting strong asset performance and deleveraging progress.
Healthcare services business agreed to acquire Gormed LLC, expanding its regional footprint and expected to add c.80,000 patients.
Financial highlights
Total portfolio value increased 2.2% quarter-on-quarter to GEL 4.64 billion in 3Q25 and 23.4% year-to-date.
Private portfolio value up 6.7% quarter-on-quarter, with large portfolio companies showing 13.5% revenue and 29.5% EBITDA growth year-over-year in 3Q25.
Free cash flow projected at US$57 million for 2025, with pro forma FCF at US$63 million, up 45.6% y-o-y per share.
Dividend income was GEL 110.1 million in 3Q25 and GEL 167.8 million in 9M25, mainly from Lion Finance Group and private businesses; 2025 outlook revised to c.GEL 200 million.
Share buybacks totaled GEL 100.2 million in 3Q25 and GEL 244.0 million in 9M25, with 15.2 million shares repurchased since demerger at a cost of US$221 million.
Outlook and guidance
Management expects continued NAV per share and sustainable EBITDA growth across large portfolio companies, supported by robust macroeconomic conditions in Georgia.
Ongoing capital returns to shareholders remain a priority, with the GEL 700 million programme scheduled through 2027.
Commitment to maintain NCC ratio below 10% and deliver consistent NAV per share growth.
Dividend inflows projected to reach GEL 200 million for the year, with per-share dividend inflows up 31% due to buybacks.
Management expects further improvement in free cash flow and cash conversion in Q4.
Latest events from Georgia Capital
- NAV/EV per share up 61.2% YoY, capital return program 80% complete, strong segment growth.CGEO
H2 202524 Feb 2026 - NAV per share surged 61.2% in FY25, supported by strong portfolio growth and capital returns.CGEO
Investor presentation24 Feb 2026 - NAV per share dropped 12.8% in 2Q24, but private portfolio EBITDA rose 17.5% y-o-y.CGEO
Q2 20241 Feb 2026 - NAV per share up 6.2% in Q3 2024, led by private portfolio gains and a major asset sale.CGEO
Q3 202418 Jan 2026 - NAV per share up 15.7% year-over-year, with strong EBITDA, buybacks, and improved liquidity.CGEO
Q4 202423 Dec 2025 - NAV per share up 17.7% in Q2 2025, with strong earnings and new capital return programme.CGEO
H1 202523 Nov 2025 - NAV per share up 11.2% in Q1 2025, with strong portfolio growth and accelerated buybacks.CGEO
Q1 202521 Nov 2025